Medicament (3004490050)
CN → US| HS编码 | 关税税率 | 原产国 | 目的国 | 文档 |
|---|---|---|---|---|
| 3003900190 | 10.0% | CN | US | 官方文档 |
| 3004490050 | 10.0% | CN | US | 官方文档 |
| 3004490070 | 10.0% | CN | US | 官方文档 |
| 3003490000 | 10.0% | CN | US | 官方文档 |
商品图片
AI分析
💊 Medicament (Medicament)
🌐 HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional Clearance Strategy
📌 Part I: Product Definition & Classification: Do You Really Understand “Medicament”?
In international trade, Medicaments refer to pharmaceutical preparations intended for therapeutic or prophylactic purposes. The classification hinges on two critical factors: 1. Purpose: Is it for treating/preventing disease? 2. Form & Composition: Is it in measured doses? Is it mixed with other substances?
⚠️ Key Distinction:
- If the medicament is mixed with other substances and put up in measured doses or retail packaging → Chapter 30, Heading 3004
- If it is not mixed or put up in non-retail forms → Chapter 30, Heading 3003
- If the specific chemical composition is unknown or generic → “Other” subheadings apply
📦 Part II: HS Code Classification Details (2026 Latest Tariff Authority Comparison)
Based on the provided data, the following HS Codes are relevant for "Medicament". All items are subject to a 10.0% Total Tax Rate due to Section 122 tariffs.
| HS Code | Product Description | Classification Logic (Based on Provided Data) | Total Tax Rate |
|---|---|---|---|
| 3003.90.01.90 | Medicaments (Other) | Fallback Rule: Name is explicitly "Medicament" (therapeutic/preventive use). Since chemical components or packaging forms are not specified, the "Other" category is used as a catch-all. No material/form conflicts detected. | 10.0% |
| 3004.49.00.50 | Medicaments (Other) | Direct Match: The name "Medicament" directly aligns with the heading’s purpose ("preparations for therapeutic or prophylactic purposes"). | 10.0% |
| 3004.49.00.70 | Medicaments (Other) | Consistent Prefix: The HS code prefix aligns with the drug category in the reference classification. No conflicts in material or form. Explicitly matches the therapeutic/prophylactic definition. | 10.0% |
| 3003.49.00.00 | Medicaments (Other) | Component-Based Inference: The name "Medicament" fits the general drug definition. Since components are not specified, it is inferred as a drug containing alkaloids or other substances, falling into the "Other" category under Heading 3003 (unmixed medicaments). | 10.0% |
🔍 Important Note:
- All four HS Codes listed result in a 10.0% Total Tax.
- The distinction between 3003 (unmixed/non-measured dose) and 3004 (mixed/measured dose) depends on specific product details not provided in the generic name "Medicament".
- Without further specification, customs may lean toward "Other" (49/90) subheadings, triggering the 10% Section 122 tariff.
💰 Part III: 2026 Latest Tariff Rate Breakdown (Including Surcharges)
✅ Applicable Country: United States (US)
✅ Origin: China (CN)
✅ Effective Time: Current (as per provided data)
🎯 1. Common Tax Structure for All Listed HS Codes
| Item | Content |
|---|---|
| Base Tariff | 0.0% (ad valorem) |
| Section 122 Surcharge | +10.0% |
| Total Tax Rate | 10.0% |
| Tax Calculation | CIF Value × 10.0% |
| De Minimis Exemption | ❌ Not Applicable (Section 122 tariffs typically apply regardless of value) |
| Legal Basis | Section 122 Tariff Provisions |
📌 Explanation:
- Base Tariff: 0% for most pharmaceuticals under normal trade relations.
- Section 122 Tariff (10%): A specific surcharge applied to certain goods, likely under recent trade policy adjustments. This is the dominant cost driver.
- No Additional 301 Tariff Mentioned: The provided data only specifies "Section 122 Tariff 10%". Unlike electronics, pharmaceuticals may not be subject to the 25% Section 301 tariff, but always verify with latest USITC lists.
🛠️ Part IV: Customs Clearance Practical Advice (Real-World Pitfall Avoidance)
✅ 1. Documentation Checklist (Essential)
| Document | Mandatory | Explanation |
|---|---|---|
| ✅ Product Specification Sheet | ✔️ | Must include: Active ingredients, dosage form (tablet, liquid, etc.), concentration, therapeutic use. |
| ✅ Labeling & Packaging Images | ✔️ | Clear view of ingredients list, expiration date, batch number, and storage conditions. |
| ✅ Certificate of Analysis (COA) | ✔️ | Proves compliance with pharmacopeial standards (USP, EP, etc.). |
| ✅ FDA Registration Number | ✔️ | For drugs imported into the US, FDA approval/registration is mandatory. |
| ✅ Commercial Invoice | ✔️ | Must explicitly state: "Medicament for [Specific Purpose]", HS Code, and Unit Price. |
| ✅ Packing List | ✔️ | Detail net/gross weight, number of packages, and contents per package. |
✅ 2. Declaration Strategy (Key Tips)
🔥 “Be Specific, Be Accurate: Generic Names Lead to Delays!”
| Scenario | Correct Declaration | Incorrect Declaration | Risk |
|---|---|---|---|
| Generic "Medicament" | Specify active ingredient + form (e.g., "Ibuprofen Tablets 200mg") | "Medicament" | ⚠️ High Risk: Customs may default to "Other" (3004.49/3003.90) and assess 10% tax or hold for inspection. |
| Mixed Medicament (3004) | Declare as "Preparation for therapeutic use, mixed with other substances, in measured doses" | "Chemical Compound" | ⚠️ Misclassification: May be wrongly placed in Chapter 29 (Chemicals) → Higher duties or regulatory hold. |
| Unmixed Medicament (3003) | Declare as "Active Pharmaceutical Ingredient (API), not mixed" | "Finished Drug" | ⚠️ Regulatory Issue: API imports require different FDA pathways than finished drugs. |
📌 Advice:
- Never use "Medicament" as the sole description. Always include:
- Active Ingredient
- Dosage Form (e.g., Tablet, Capsule, Solution)
- Strength (e.g., 500mg)
- Intended Use (e.g., "For treatment of headache")
- This reduces the chance of being classified under "Other" (90/49) subheadings and helps confirm if Section 122 applies.
✅ 3. Special Cases & Handling
| Situation | Handling Advice |
|---|---|
| OEM/White Label Drugs | Provide manufacturer authorization and FDA listing numbers. Avoid "private label" terms; use generic chemical names. |
| Drugs for Personal Use | Must still comply with FDA regulations. Quantities should be reasonable (e.g., <90 days’ supply). |
| Controlled Substances | Require DEA Registration and special permits. Misdeclaration leads to seizure and penalties. |
| Herbal/Botanical Medicaments | May be classified under Chapter 12 or 30 depending on preparation. Provide full ingredient list to avoid misclassification. |
🌍 Part V: Global Market Comparison (2026 Latest)
| Country/Region | Recommended HS Code | Tariff | Certification Requirements | Notes |
|---|---|---|---|---|
| 🇺🇸 United States | 3004.49.00.50 / 3003.90.01.90 |
10.0% (Section 122) | FDA Approval/Registration + NDC Code | High compliance cost. Section 122 tax applies. |
| 🇨🇳 China | 3004.49.00.00 |
5-10% (varies by ingredient) | NMPA (formerly CFDA) Approval | Import duties may be lower, but regulatory hurdles are high. |
| 🇪🇺 European Union | 3004.90.90 |
6.5% | CE Marking (if medical device) or Marketing Authorization (Medicinal Product) | No Section 122. Standard EU duty applies. |
| 🇬🇧 United Kingdom | 3004.90.90 |
6.5% | MHRA Approval | Post-Brexit rules apply. |
| 🇦🇺 Australia | 3004.90.00 |
5% | TGA (Therapeutic Goods Administration) Approval | No Section 122. |
📌 Conclusion:
- The US is unique in applying the 10.0% Section 122 tariff to generic medicaments.
- Regulatory compliance (FDA) is the biggest barrier, not just tariff costs.
- Always verify if your specific active ingredient is exempt from Section 122 (some APIs may be treated differently).
📌 Part VI: Common Mistakes & Pitfall Avoidance (Lessons Learned)
❌ Mistake 1: Declaring only as "Medicament" without specifying ingredients or form.
👉 Consequence: Customs may assign a "Other" HS Code → 10% tax + possible inspection delay.
❌ Mistake 2: Misclassifying finished drugs as chemical compounds (Chapter 29).
👉 Consequence: Regulatory hold by FDA/Customs → Seizure or return.
❌ Mistake 3: Ignoring Section 122 Tariff.
👉 Consequence: Unexpected 10% additional cost at clearance → Margin erosion.
❌ Mistake 4: Using incorrect NDC (National Drug Code) or FDA registration numbers.
👉 Consequence: Import rejection by FDA → No entry into the US market.
✅ Correct Approach:
"Ibuprofen Tablets, 200mg, for oral use, packaged in blisters, FDA-listed, Manufacturer: [Company], NDC: [Number]"
🎯 Part VII: Conclusion: Professional Declaration, Safe Clearance, Cost Control!
🎯 Remember the Golden Rules:
🔹 "Specificity Prevents Penalties: Name, Form, Strength, Purpose."
🔹 "Section 122 Applies: 10% Tax is Inevitable for Generic Medicaments."
🔹 "FDA First, Tariff Second: Compliance is Key to Market Access."
📌 Pro Tip:
If your medicament is active pharmaceutical ingredient (API) rather than a finished drug, consider different HS Codes (e.g., under Chapter 29). API imports may have different tax treatments and less stringent retail packaging requirements.
🚀 Recommendation:
- Apply for Advance Ruling (Ruling Letter) from US Customs if uncertain.
- Engage a FDA-licensed US Agent for seamless clearance.
- Double-check Section 122 Exemptions for your specific active ingredient.
📣 Immediate Action:
📞 Contact: Professional Customs Broker + FDA Compliance Consultant
📄 Prepare: Product Spec Sheet + FDA Registration Docs + Detailed Declaration
🚀 Goal: Smooth Clearance, Zero Surprises, Maximized Profit!
✨ Professional Clearance Starts with Precise Classification!
💼 Your Every Cent Matters – Calculate Accurately, Declare Precisely!
用户评价
关于 HS 编码归类
协调制度(HS)是由世界海关组织(WCO)制定的国际贸易商品分类标准。全球 200 多个国家采用 HS 系统作为海关关税、贸易统计和进出口监管的基础。
每个 HS 编码遵循以下层级结构:
- 章(2 位)——商品大类(例如:第 84 章:机器和机械设备)
- 品目(4 位)——章内的更具体分类
- 子目(6 位)——国际通用细分,所有 WCO 成员国统一使用
- 本国细分(8-10 位)——各国自行扩展的细分编码,如美国 HTSUS 10 位编码
正确的 HS 编码归类对于顺利通关、准确缴纳关税和遵守贸易法规至关重要。错误归类可能导致海关延误、多缴关税或罚款。
从CN进口到US时,适用的关税税率可能包括:
- 最惠国(MFN)税率——适用于 WTO 成员国的标准关税税率
- 普通税率——适用于无贸易协定国家
- 贸易救济关税——附加关税,如 301 条款(反倾销)、232 条款(国家安全)或反补贴税
本页内容仅供参考。如需正式归类,请咨询当地海关或持牌报关代理。